Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > SEC filing

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Feb 24, 2021 3:11pm

69 Views

Post# 32649409

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SEC filing

Mainly because it should be so easy to fix!

jfm1330 wrote: Sorry, but if a potential investor comes here to learn more about the company the first thing he will read is repetitive posts stating that this company is plagued with incompetent management and BOD. After that he will ask himself why are these people writing all that still invested in this company?

ANALIAS00 wrote: One of the first thing Paul said was about being accountable. If Dubuc suggested that Nasdaq was the way to go and at the end that made no difference at all, it would be interesting to insure noone got bonus for that. And dont get me wrong. Nasdaq idea was good, they (Dubuc's strategy or absence of strategy ?) just failed to optimize what Nasdaq could have brought to THTX days, weeks and months after getting there. So yes THTX must insure bonus are proportionnal to results and THTX must insure that no result = no bonus.

realitycheck4u wrote: He said we should claw back bonues. Kinda stupid to go back and copy/paste what he did, and to think it's even close to reality. You forget, I am realityCheck4U

ANALIAS00 wrote: So you are saying we should forget and forgive all bad decisions because their PR are full of "should, may, we beleive, potential,..." ? I for sure do not think so.

realitycheck4u wrote: Here's why.

“We believe (they were wrong) that being listed on NASDAQ will help (not "for sure", just help) to foster interest (not deliver it for sure, just "forster it") from more potential (not fure sure, just potential) investors and financial analysts, and that it should (not for sure) result in increased liquidity for investors.

If you cannot read a statement without also reading what it means, that's a problem my friend.

palinc2000 wrote: Lol!!!

realitycheck4u wrote: You are losing my respect. That's the stupidest comment on this board in a very long time.

palinc2000 wrote: From the August 12 2019 PR re application for Nasdaq Listing......I am not 100% certain but I think part of Dubuc s bonus was based on Listing on the Naz.......IF this is the case then maybe .there should be clawback clauses on bonuses

“We believe that being listed on NASDAQ will help to foster interest from more potential investors and financial analysts, and that it should result in increased liquidity for investors. Theratechnologies will enter NASDAQ with a strong commercial portfolio and a research pipeline that will undoubtedly attract more attention and be better recognized,” said Philippe Dubuc, Senior Vice-President and Chief Financial Officer, Theratechnologies Inc